Earnings History Data for Co-Diagnostics, Inc. (CODX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Co-Diagnostics, Inc.
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
07-11-2024 | AH | CODX | Co-Diagnostics, Inc. | 38.61 | -0.32 | -0.33 | -0.20 | Co-Diagnostics GAAP EPS of -$0.32 beats by $0.01, revenue of $0.64M beats by $0.26M [11/7/2024 4:26 PM] |
1.15 | -0.03 (-2.54%) |
1.19 | 0.01 (0.85%) |
1.00 - 2.23 | 123,956 | 60,000 | 217 | ||
08-08-2024 | AH | CODX | Co-Diagnostics, Inc. | 34.72 | -0.25 | -0.34 | -0.31 | Co-Diagnostics GAAP EPS of -$0.25 beats by $0.09, revenue of $2.66M beats by $2.28M [8/8/2024 4:14 PM] |
1.11 | 0.09 (9.31%) |
1.05 | 0.03 (3.43%) |
0.98 - 1.73 | 99,837 | 70,000 | 346 | ||
09-05-2024 | AH | CODX | Co-Diagnostics, Inc. | 39.39 | -0.31 | -0.21 | -0.20 | Co-Diagnostics GAAP EPS of -$0.31 misses by $0.10, revenue of $0.47M misses by $2.58M [5/9/2024 4:05 PM] |
1.10 | -0.12 (-10.16%) |
0.0 | 0.0 (0.00%) |
0.98 - 1.89 | 148,361 | 50,000 | 0 | ||
14-03-2024 | AH | CODX | Co-Diagnostics, Inc. | 35.93 | -0.50 | -0.20 | -0.32 | Co-Diagnostics GAAP EPS of -$1.20 misses by $0.30, revenue of $6.8M misses by $0.08M [3/14/2024 4:18 PM] |
1.06 | -0.13 (-10.92%) |
1.15 | -0.04 (-3.36%) |
0.98 - 2.99 | 189,793 | 50,000 | 6,614 | ||
09-11-2023 | AH | CODX | Co-Diagnostics, Inc. | 37.56 | -0.20 | -0.29 | -0.04 | Co-Diagnostics GAAP EPS of -$0.20 beats by $0.09, revenue of $2.46M beats by $2.26M [11/9/2023 4:14 PM] |
1.13 | -0.14 (-11.02%) |
1.21 | -0.06 (-4.72%) |
0.98 - 3.84 | 125,552 | 60,000 | 3,956 | ||
10-08-2023 | AH | CODX | Co-Diagnostics, Inc. | 41.46 | -0.31 | -0.23 | -0.10 | Co-Diagnostics GAAP EPS of -$0.31 misses by $0.07, revenue of $0.2M misses by $0.3M [8/10/2023 4:02 PM] |
1.19 | -0.02 (-1.26%) |
1.20 | -0.01 (-0.83%) |
0.98 - 6.68 | 90,962 | 150,000 | 100 | ||
11-05-2023 | AH | 4:15 PM ET (May 11) |
CODX | Co-Diagnostics, Inc. | 41.13 | -0.20 | -0.22 | 0.26 | Co-Diagnostics GAAP EPS of -$0.20 beats by $0.03, revenue of $0.61M misses by $0.49M [5/11/2023 4:02 PM] |
1.33 | 0.09 (7.26%) |
1.36 | 0.05 (3.42%) |
1.20 - 7.13 | 255,044 | 100,000 | 1,698 | |
16-03-2023 | AH | 4:15 PM ET (Mar 16) |
CODX | Co-Diagnostics, Inc. | 93.68 | -0.32 | -0.15 | 0.25 | Co-Diagnostics GAAP EPS of -$0.45 misses by $0.54, revenue of $34.22M misses by $4.1M [3/16/2023 4:02 PM] |
2.52 | -0.44 (-14.86%) |
2.71 | -0.25 (-8.45%) |
2.26 - 7.13 | 162,107 | 70,000 | 1,475 | |
10-11-2022 | AH | 4:00 PM ET (Nov 10) |
CODX | Co-Diagnostics, Inc. | 119.92 | -0.04 | -0.05 | 0.38 | Co-Diagnostics GAAP EPS of -$0.04, revenue of $5.1M [11/10/2022 4:16 PM] |
3.68 | 0.22 (6.36%) |
3.25 | -0.21 (-6.07%) |
2.76 - 10.90 | 246,010 | 150,000 | 1,735 | |
11-08-2022 | AH | 4:00 PM ET (Aug 11) |
CODX | Co-Diagnostics, Inc. | 193.57 | -0.10 | 0.15 | 0.33 | Co-Diagnostics GAAP EPS of -$0.08 misses by $0.18, revenue of $5.02M misses by $13.98M [8/11/2022 4:07 PM] |
4.46 | -2.00 (-30.96%) |
4.35 | -2.11 (-32.66%) |
3.66 - 11.82 | 3,470,070 | 720,000 | 407,310 | |
12-05-2022 | AH | 4:00 PM ET (May 12) |
CODX | Co-Diagnostics, Inc. | 131.45 | 0.26 | 0.18 | 0.26 | Co-Diagnostics GAAP EPS of $0.34 beats by $0.17, revenue of $22.7M beats by $1.53M [5/12/2022 4:03 PM] |
4.58 | 0.62 (15.66%) |
4.17 | 0.21 (5.30%) |
3.66 - 11.82 | 299,548 | 260,000 | 5,016 | |
24-03-2022 | AH | 4:00 PM ET (Mar 24) |
CODX | Co-Diagnostics, Inc. | 188.67 | 0.25 | 0.15 | 0.43 | Co-Diagnostics GAAP EPS of $1.23 beats by $0.13, revenue of $97.89M misses by $0.53M [3/24/2022 4:04 PM] |
5.75 | -0.76 (-11.67%) |
6.34 | -0.17 (-2.57%) |
5.00 - 11.82 | 974,327 | 624,783 | 453 | |
11-11-2021 | AH | 4:00 PM ET (Nov 11) |
CODX | Co-Diagnostics, Inc. | 248.45 | 0.38 | 0.21 | 0.53 | Co-Diagnostics EPS beats by $0.17, beats on revenue [11/11/2021 4:02 PM] |
9.29 | 0.64 (7.40%) |
9.01 | 0.36 (4.16%) |
7.01 - 20.69 | 1,576,799 | 500,000 | 120,205 | |
|
||||||||||||||||||
12-08-2021 | AH | 4:00 PM ET (Aug 12) |
CODX | Co-Diagnostics, Inc. | 282.45 | 0.33 | 0.23 | 0.43 | 10.57 | 0.90 (9.30%) |
10.50 | 0.83 (8.58%) |
7.01 - 22.15 | 6,496,457 | 1,480,000 | 77,906 | ||
|
||||||||||||||||||
13-05-2021 | AH | 4:00 PM ET (May 13) |
CODX | Co-Diagnostics, Inc. | 220.73 | 0.26 | 0.20 | -0.05 | Co-Diagnostics EPS beats by $0.04, beats on revenue [5/13/2021 4:11 PM] |
8.46 | 1.30 (18.16%) |
7.53 | 0.37 (5.17%) |
7.01 - 30.99 | 2,076,990 | 780,000 | 16,246 | |
25-03-2021 | AH | 4:00 PM ET (Mar 25) |
CODX | Co-Diagnostics, Inc. | 384.74 | 0.43 | 0.49 | -0.10 | Co-Diagnostics EPS misses by $0.04, beats on revenue [3/25/2021 4:04 PM] |
9.68 | -2.44 (-20.13%) |
11.21 | -0.91 (-7.51%) |
6.81 - 30.99 | 3,648,368 | 870,000 | 46,005 | |
|
||||||||||||||||||
16-11-2020 | AH | 4:00 PM ET (Nov 16) |
CODX | Co-Diagnostics, Inc. | 429.41 | 0.53 | 0.54 | -0.10 | Co-Diagnostics EPS misses by $0.10, misses on revenue [11/16/2020 4:07 PM] |
11.84 | -1.75 (-12.88%) |
11.86 | -1.73 (-12.73%) |
0.86 - 30.99 | 5,089,971 | 2,403,752 | 163,339 | |
|
||||||||||||||||||
13-08-2020 | AH | 4:00 PM ET (Aug 13) |
CODX | Co-Diagnostics, Inc. | 638.38 | 0.43 | 0.61 | -0.08 | Co-Diagnostics EPS misses by $0.16, misses on revenue [8/13/2020 4:29 PM] |
16.32 | -4.68 (-22.29%) |
17.48 | -3.52 (-16.76%) |
0.85 - 30.99 | 6,126,177 | 4,656,830 | 210,134 | |
|